Evidence map›Paper›PMID 27627814›Full record

ArticleDrug and alcohol dependence2016

Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.

M G LeSage, M Staley, P Muelken, J R Smethells, I Stepanov, R I Vogel, P R Pentel, A C Harris

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M G LeSageDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States; Department of Psychology, University of Minnesota, Minneapolis, MN, 55455, United States. Electronic address: lesag002@umn.edu.
M StaleyDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States.
P MuelkenDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States.
J R SmethellsDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States; Department of Psychiatry, University of Minnesota, Minneapolis, MN, 55455, United States.
I StepanovMasonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
R I VogelMasonic Cancer Center Biostatistics and Bioinformatics Core, University of Minnesota, Minneapolis, MN, United States.
P R PentelDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
A C HarrisDepartment of Medicine, Minneapolis Medical Research Foundation, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States; Department of Psychology, University of Minnesota, Minneapolis, MN, 55455, United States.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, SHIELDS, PETER G. · 2012 to 2016
$13.3M
Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
NCATS NIH HHS UL1 TR002494NCI NIH HHS U19 CA157345NIDA NIH HHS T32 DA007097
6 · The paper itself

Abstract

backgroundThe popularity of electronic cigarettes (ECs) has increased dramatically despite their unknown health consequences. Because the abuse liability of ECs is one of the leading concerns of the Food and Drug Administration (FDA), models to assess it are urgently needed to inform FDA regulatory decisions regarding these products. The purpose of this study was to assess the relative abuse liability of an EC liquid compared to nicotine alone in rats. Because this EC liquid contains non-nicotine constituents that may enhance its abuse liability, we hypothesized that it would have greater abuse liability than nicotine alone.

methodsNicotine alone and nicotine dose-equivalent concentrations of EC liquid were compared in terms of their acute effects on intracranial self-stimulation (ICSS) thresholds, acquisition of self-administration, reinforcing efficacy (i.e., elasticity of demand), blockade of these behavioral effects by mecamylamine, nicotine pharmacokinetics and nicotinic acetylcholine receptor binding and activation.

resultsThere were no significant differences between formulations on any measure, except that EC liquid produced less of an elevation in ICSS thresholds at high nicotine doses.

conclusionsCollectively, these findings suggest that the relative abuse liability of this EC liquid is similar to that of nicotine alone in terms of its reinforcing and reinforcement-enhancing effects, but that it may have less aversive/anhedonic effects at high doses. The present methods may be useful for assessing the abuse liability of other ECs to inform potential FDA regulation of those products.

Indexed as

Electronic Nicotine Delivery SystemsReinforcement, PsychologySelf AdministrationAnimalsDose-Response Relationship, DrugMaleMecamylamineNicotineNicotinic AgonistsNicotinic AntagonistsRatsRats, Sprague-DawleySelf StimulationMecamylamineNicotineNicotinic AgonistsNicotinic AntagonistsBehavioral economicsE-cigarettesIntracranial self-stimulationNicotineRatSelf-administrationTobacco control policy

Identifiers

PMID27627814
PMCPMC5257285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.